Core Insights - The report highlights the changes in the Hong Kong Stock Connect holdings, indicating significant increases and decreases in ownership percentages for various companies as of September 1, 2025 [1][2][3]. Group 1: Increased Holdings - Aikang Medical (01789) saw the largest increase in holdings, up by 1.59%, bringing its total to 20.34% [1]. - Yimai Sunshine (02522) and Shanghai Fudan (01385) also experienced notable increases of 1.19% and 0.91%, with new holdings of 38.82% and 41.13% respectively [1]. - Other companies with significant increases include Jingtai Holdings (02228) and Fourth Paradigm (06682), both up by 0.86%, with holdings of 41.75% and 46.65% respectively [1]. Group 2: Decreased Holdings - Hang Seng China Enterprises (02828) experienced the largest decrease, down by 15.91%, now holding only 0.50% [2]. - Other notable decreases include the Tracker Fund of Hong Kong (02800) and Southern Hang Seng Technology (03033), which fell by 7.39% and 2.67%, with holdings of 0.69% and 59.48% respectively [2]. - Companies like Huaxia Hang Seng Biotechnology (03069) and Yuzhou Group (01628) also saw reductions of 1.59% and 1.27%, with holdings of 13.93% and 2.06% respectively [2]. Group 3: Five-Day Changes - Over the last five trading days, Anjijia Food (02648) led with a 4.24% increase, reaching a holding of 16.87% [3]. - Other companies with significant five-day increases include Jinli Permanent Magnet (06680) and Ganfeng Lithium (01772), which rose by 3.94% and 3.34%, with holdings of 28.00% and 34.97% respectively [3]. - Companies like Jingtai Holdings (02228) and Times Angel (06699) also saw increases of 3.12% and 2.06%, with holdings of 41.75% and 23.15% respectively [3]. Group 4: Twenty-Day Changes - In the last twenty days, Anjijia Food (02648) had the highest increase at 14.45%, with a holding of 16.87% [4]. - Changfei Optical Fiber (06869) and Yimai Sunshine (02522) also saw significant increases of 8.06% and 7.96%, with holdings of 54.02% and 38.82% respectively [4]. - Other notable increases include Meizhong Jiahe (02453) and Jingtai Holdings (02228), which rose by 7.16% and 6.99%, with holdings of 37.60% and 41.75% respectively [4].

Core Viewpoint - The company has successfully launched its first batch of CT chest lesion annotation data on the Shanghai Data Exchange, marking a significant step in the marketization of data assets and showcasing its expertise in medical imaging data [1] Group 1: Data Transaction Details - The data set was officially approved and launched on August 25, 2025, through the Beijing International Big Data Exchange [1] - A tripartite cooperation contract was established between the company's subsidiary, a data technology and application company, and the Beijing International Big Data Exchange [1] - The first data transaction was completed on September 1, 2025, in accordance with the tripartite cooperation contract [1] Group 2: Market Implications - The transaction aims to promote the standardized integration and market-oriented trading of data elements [1] - Conducting the transaction on the North Data Exchange platform ensures the legality and compliance of the trading process, protecting the rights and interests of all parties involved [1] - This collaboration provides a new model for monetizing the company's core data assets and further highlights its professional capabilities and market value in the medical imaging data sector [1]

Core Viewpoint - The company successfully passed compliance review and launched its data set on the Beijing International Big Data Exchange, marking a significant step in the marketization of data elements [1] Group 1: Data Transaction - The company's subsidiary, Beijing Yimai Information, entered into a tripartite cooperation contract with a data technology and application company and the Beijing International Big Data Exchange [1] - The first batch of data transactions was completed on September 1, 2025, under the tripartite cooperation contract [1] - This transaction aims to promote the standardized integration and market-oriented trading of data elements [1] Group 2: Market Position and Value - The transaction on the Beijing International Big Data Exchange ensures the legality and compliance of the trading process while protecting the rights and interests of all parties involved [1] - This collaboration provides a new model for monetizing the company's core data assets and further highlights its professional capabilities and market value in the field of medical imaging data [1]

Core Viewpoint - The company, Yimai Sunshine, successfully launched its data set on the Beijing International Big Data Exchange after passing compliance review, marking a significant step in data asset monetization and showcasing its expertise in medical imaging data [1] Group 1: Data Transaction Details - The data set was officially launched on August 25, 2025, with the product number PD2025082117370118 [1] - A tripartite cooperation contract was signed between the company's subsidiary, Beijing Yimai Information, a data technology and application company, and the Beijing International Big Data Exchange [1] - The first data transaction was completed with the data user on September 1, 2025, under the terms of the cooperation contract [1] Group 2: Market Implications - The transaction aims to promote the standardized integration and market-oriented trading of data elements [1] - Conducting the transaction on the Beijing International Big Data Exchange ensures legal compliance and protects the rights of all parties involved [1] - This collaboration provides a new model for monetizing the company's core data assets and highlights its professional capabilities and market value in the medical imaging data sector [1]

（於中華人民共和國註冊成立的股份有限公司） 香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性 或完整性亦不發表任何聲明，並明確表示，概不就因本公告全部或任何部分內容所產生或因依 賴該等內容而引致的任何損失承擔任何責任。 Jiangxi Rimag Group Co., Ltd. 江西一脈陽光集團股份有限公司 （股份代號：2522） 自願公告 完成首批數據交易 茲提述江西一脈陽光集團股份有限公司（「本公司」）日期為2025年4月2日的公告 （「該公告」），內容有關本公司首批在上海數據交易所上架的CT胸部病變標注數據 （「數據集」）。除另有說明外，本公告所用詞彙與該公告所界定者具有相同涵義。 董事會欣然宣佈，於2025年8月25日，數據集正式通過北京國際大數據交易所 （「北數所」）合規審核並成功上架（上架產品號：PD2025082117370118）。本公司 的附屬公司北京一脈信息作為數據提供方，與一家從事數據技術及應用的公司 （「數據使用方」）及北京國際大數據交易所有限責任公司訂立了數據交易三方合作 合同（「數據交易三方合作合同」），並於2025年9月1日本集團根據數據交易三方 ...

Core Viewpoint - The company, Yipai Yangguang (02522.HK), has successfully completed a placement agreement, fulfilling all conditions as of August 28, 2025, and has placed a total of 35 million shares at a price of HKD 16.76 per share [1]. Group 1 - The placement agreement was executed with at least six subscribers [1]. - The total number of shares placed amounts to 35 million [1]. - The placement price per share is set at HKD 16.76 [1].

Group 1 - The company, Yipai Sunshine (02522), announced the completion of a placement agreement on August 28, 2025, with all conditions met [1] - The placement agent successfully placed a total of 35 million shares at a price of HKD 16.76 per share to no less than six subscribers [1] - The shares placed represent approximately 13.55% of the number of H shares issued prior to completion and about 9.58% of the total issued shares, excluding treasury shares [1] Group 2 - After the placement, the issued H shares will increase, representing approximately 11.93% of the enlarged number of H shares and about 8.75% of the enlarged total issued shares, excluding treasury shares [1]

配售代理已根据配售协议的条款及条件按每股配售股份16.76港元的配售价成功配售予不少于六名承配 人合共3500万股配售股份，相当于(i)紧接完成前已发行H股(不包括库存股份)数目的约13.55%及已发行 股份(不包括库存股份)数目的约9.58%;及(ii)经配发及发行配售股份扩大后已发行H股(不包括库存股份) 数目的约11.93%及已发行股份(不包括库存股份)数目的约8.75%。 一脉阳光(02522)发布公告，根据配售协议条款，配售协议所载全部条件均已获达成且完成已于2025年8 月28日进行。 ...

FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 公司名稱： 江西一脈陽光集團股份有限公司 呈交日期： 2025年8月28日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 普通股 | 股份類別 H | | | 於香港聯交所上市 | 是 | | | | 證券代號 (如上市) 02522 | 說明 | | | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | | 庫存股份變動 | | | | | | 事件 | 已發行股份（不包括庫存股份）數 目 | 佔有關事件 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性 或完整性亦不發表任何聲明，並明確表示，概不就因本公告全部或任何部分內容所產生或因依 賴該等內容而引致的任何損失承擔任何責任。 本公告或其任何副本概不得直接或間接於美國境內或有關刊發或派發屬違法的任何其他司法權 區刊發或派發。本公告僅作參考用途，並不構成收購、購買或認購本公司任何證券之邀請或要 約。 本公告並不構成或組成於美國境內或有關發售屬違法的任何其他司法權區出售或購買或認購證 券的任何要約或招攬的一部分。本公告所述本公司股份並無亦不會根據1933年美國證券法（經 修訂）（「美國證券法」）登記，且不得於美國境內提呈發售或出售，惟根據美國證券法登記規定 進行登記者或獲豁免遵守該等登記規定者除外。本公司無意根據美國證券法登記本公告內所指 之任何證券，或在美國境內進行證券公開發售。 Jiangxi Rimag Group Co., Ltd. 江西一脈陽光集團股份有限公司 （於中華人民共和國註冊成立的股份有限公司） 配售代理已根據配售協議的條款及條件按每股配售股份16.76港元的配售價成功配 售予不少於六名承配人合共35,000,0 ...